Patent foramen ovale and paradoxical thromboembolism. Which treatment is the most appropriate?

Patent foramen ovale (PFO) has been associated with a higher frequency of cryptogenic stroke, transient ischemic attack and migraines. PFO treatment, based on percutaneous closure versus non-closure with medical therapy, remains controversial with a general tendency to propose a closure for symptomatic patients for transient ischemic attack or stroke [1–10].

Source: International Journal of Cardiology - January 9, 2016 Category: Cardiology Authors: Francesco Masetti, Patrizia Borra, Salvatore Maviglia Tags: Correspondence Source Type: research